Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: Magnetic Resonance Imaging (MRI)|DRUG: Gadavist
Sponsor: University of California, San Francisco
Collaborators: National Cancer Institute (NCI)